What patent covers Ozempic (and who owns it)?
Ozempic (semaglutide) is protected by multiple patents and patent rights in different jurisdictions. Those patent portfolios commonly include protection for the active ingredient (semaglutide), specific formulations/delivery methods, manufacturing processes, and related method-of-use claims, and they can be held by different entities depending on the patent and country.
DrugPatentWatch.com tracks Ozempic-related patent activity and can help you see which patents are listed as expiring and how long exclusivity may last in specific regions: DrugPatentWatch: Ozempic patents.
When does the Ozempic patent expire?
Patent expiration depends on the exact patent(s) in question (and the country), and it can also be affected by exclusivity extensions (for example, pediatric or other regulatory exclusivity). Because Ozempic has multiple patents, there is no single “the Ozempic patent expires on X date” answer that applies to all rights.
You can use DrugPatentWatch’s Ozempic listing to check expiration dates tied to specific patents and related exclusivity entries: DrugPatentWatch: Ozempic patents.
Is Ozempic’s protection mainly about the drug ingredient or the pen/device?
Protection can include both drug-related claims and product-use or delivery-related claims. That means even if the “active ingredient” protections narrow, other patents (like formulation, manufacturing, or device/method-of-use claims) may still block or delay a generic or biosimilar entry.
To see what’s specifically claimed in the patents listed for Ozempic, use the patent-by-patent view on DrugPatentWatch: DrugPatentWatch: Ozempic patents.
Can a generic or biosimilar enter before all Ozempic patents expire?
Often, partial entry is possible if a challenger can “design around” the particular claims still in force, or if some patents expire earlier than others. In practice, the first competitor able to launch may depend on which specific patents are still enforceable when a regulatory approval request is made.
For a current picture of what patents are listed for Ozempic (and related expiration timelines), check: DrugPatentWatch: Ozempic patents.
Where should you look if you mean “Fuzeon” (not “Ozempic”)?
Your query reads like “Patent fu ozempic.” If you meant a different drug name (for example “Fuzeon,” which is a different medication), the patent situation would be completely different.
If you confirm the exact product name (and country, if you know it), I can point you to the correct patent entry.
Sources
- DrugPatentWatch: Ozempic patents